Published in Brain on January 01, 1998
Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis. J Exp Med (2006) 2.51
Matrix metalloproteinase-9 and autoimmune diseases. J Clin Immunol (2006) 1.66
Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions. J Clin Invest (1999) 1.64
ATR inhibition broadly sensitizes ovarian cancer cells to chemotherapy independent of BRCA status. Cancer Res (2013) 1.16
The role of microglia and matrix metalloproteinases involvement in neuroinflammation and gliomas. Clin Dev Immunol (2013) 1.01
Cleavage of myelin associated glycoprotein by matrix metalloproteinases. J Neuroimmunol (2007) 0.98
PEG minocycline-liposomes ameliorate CNS autoimmune disease. PLoS One (2009) 0.90
Friends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative Diseases. Mediators Inflamm (2015) 0.89
Matrix metalloproteinase-7 facilitates immune access to the CNS in experimental autoimmune encephalomyelitis. BMC Neurosci (2009) 0.88
Phosphodiesterase 4-targeted treatments for autoimmune diseases. BMC Med (2013) 0.88
Infiltration of CCR2+Ly6Chigh Proinflammatory Monocytes and Neutrophils into the Central Nervous System Is Modulated by Nicotinic Acetylcholine Receptors in a Model of Multiple Sclerosis. J Immunol (2016) 0.83
Matrix Metalloproteinases in Non-Neoplastic Disorders. Int J Mol Sci (2016) 0.81
Ligation of the jugular veins does not result in brain inflammation or demyelination in mice. PLoS One (2012) 0.81
Expression and arrangement of extracellular matrix proteins in the lungs of mice infected with Paracoccidioides brasiliensis conidia. Int J Exp Pathol (2008) 0.80
Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers. J Cereb Blood Flow Metab (2016) 0.77
Interleukin-17 impedes Schwann cell-mediated myelination. J Neuroinflammation (2014) 0.76
Matrix metalloproteinases, synaptic injury, and multiple sclerosis. Front Psychiatry (2010) 0.76
The role of angiogenesis in the pathology of multiple sclerosis. Vasc Cell (2014) 0.76
Rational design of antirheumatic prodrugs specific for sites of inflammation. Arthritis Rheumatol (2015) 0.75
Oral Tolerance Induction in Experimental Autoimmune Encephalomyelitis with Candida utilis Expressing the Immunogenic MOG35-55 Peptide. PLoS One (2016) 0.75
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol (2001) 24.36
Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet (2001) 11.12
Movement of internalized ligand-receptor complexes along a continuous endosomal reticulum. Nature (1990) 5.41
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A (2000) 4.85
Validity of accelerometry for the assessment of moderate intensity physical activity in the field. Med Sci Sports Exerc (2000) 4.60
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology (2006) 4.38
Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol (1999) 3.67
Kinase activity controls the sorting of the epidermal growth factor receptor within the multivesicular body. Cell (1990) 3.65
Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest (1994) 3.58
Role of the human transferrin receptor cytoplasmic domain in endocytosis: localization of a specific signal sequence for internalization. J Cell Biol (1990) 3.24
Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide. Leukemia (2012) 3.04
Design and therapeutic application of matrix metalloproteinase inhibitors. Chem Rev (1999) 2.96
Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology (1996) 2.94
Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa. Ann Intern Med (2000) 2.80
Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Ann Neurol (1998) 2.47
Hemolysis by asbestos. Environ Res (1971) 2.41
Statins as immunomodulators: comparison with interferon-beta 1b in MS. Neurology (2002) 2.34
Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains. Proc Natl Acad Sci U S A (1997) 2.34
Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial. Neurology (2008) 2.29
Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun (1992) 2.25
Retroviral diversity and distribution in vertebrates. J Virol (1998) 2.22
Determinants of increased energy expenditure in HIV-infected women. Am J Clin Nutr (1998) 2.21
The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol (1993) 2.13
The role of B cells and autoantibodies in multiple sclerosis. Ann Neurol (2000) 2.07
Towards MRI guided surgical manipulator. Med Sci Monit (2001) 1.97
Multiple intravenous dose pharmacokinetics of ceftriaxone in man. Chemotherapy (1981) 1.96
Clinical features and outcome of severe malaria in Gambian children. Clin Infect Dis (1995) 1.96
Laparoscopic nephrectomy: the experience of the laparoscopy working group of the German Urologic Association. J Urol (1998) 1.93
P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol (2001) 1.92
The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Ann Neurol (1993) 1.92
Changes in regional fat redistribution and the effects of estrogen during spontaneous weight gain in women with anorexia nervosa. Am J Clin Nutr (2001) 1.91
Best Practice No 176: Updated recommendations for HER2 testing in the UK. J Clin Pathol (2004) 1.90
Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res (2001) 1.90
A randomized, double-blind, dose-comparison study of weekly interferon beta-1a in relapsing MS. Neurology (2002) 1.86
A study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosis. Mult Scler (2002) 1.86
Evaluation of alternate coupling reagents to replace alpha-naphthyl amine for the detection of nitrate reduction. Microbios (1976) 1.85
Clinical utility of blood cultures drawn from indwelling central venous catheters in hospitalized patients with cancer. Ann Intern Med (1999) 1.83
Immunohistochemical detection of steroid receptors in breast cancer: a working protocol. UK Receptor Group, UK NEQAS, The Scottish Breast Cancer Pathology Group, and The Receptor and Biomarker Study Group of the EORTC. J Clin Pathol (2000) 1.81
MRI white matter hyperintensities: three-year follow-up of the Austrian Stroke Prevention Study. Neurology (1999) 1.80
A simple sensitive bioassay for interleukin-1 which is unresponsive to 10(3) U/ml of interleukin-2. J Immunol Methods (1987) 1.80
Monoclonal antibodies against defined epitopes of the human transferrin receptor cytoplasmic tail. Biochim Biophys Acta (1992) 1.76
Preceding infections, immune factors, and outcome in Guillain-Barré syndrome. Neurology (2001) 1.74
Objective monitoring of physical activity using motion sensors and heart rate. Res Q Exerc Sport (2000) 1.73
Investigating fatigue of less than 6 months' duration. Guidelines for family physicians. Can Fam Physician (1999) 1.73
Improved diffusion-weighted single-shot echo-planar imaging (EPI) in stroke using sensitivity encoding (SENSE). Magn Reson Med (2001) 1.69
Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study. Brain (1999) 1.67
Extracorporeal shock-wave lithotripsy: one-year experience with the Dornier lithotripter. Eur Urol (1985) 1.66
Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis. Brain (2001) 1.65
Transforming growth factor-beta 1 in the rat brain: increase after injury and inhibition of astrocyte proliferation. J Cell Biol (1992) 1.64
Isolation and characterization of an oligodendrocyte precursor-derived B-cell epitope in multiple sclerosis. Ann Neurol (1998) 1.60
Crystal structure of an integrin-binding fragment of vascular cell adhesion molecule-1 at 1.8 A resolution. Nature (1995) 1.55
Matrix metalloproteinases and processing of pro-TNF-alpha. J Leukoc Biol (1995) 1.54
A central role for astrocytes in the inflammatory response to beta-amyloid; chemokines, cytokines and reactive oxygen species are produced. J Neuroimmunol (1999) 1.53
The t complex polypeptide 1 (TCP-1) is associated with the cytoplasmic aspect of Golgi membranes. Cell (1989) 1.52
Human kidney 11 beta-hydroxysteroid dehydrogenase: regulation by adrenocorticotropin? Eur J Endocrinol (1996) 1.52
MRI evidence of past cerebral microbleeds in a healthy elderly population. Neurology (1999) 1.50
Animal models for autoimmune demyelinating disorders of the nervous system. Mol Med Today (2000) 1.49
Diffusion-weighted imaging of patients with subacute cerebral ischemia: comparison with conventional and contrast-enhanced MR imaging. AJNR Am J Neuroradiol (2000) 1.49
Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. Br J Cancer (1993) 1.48
Fasting hyperinsulinemia and changes in regional body composition in human immunodeficiency virus-infected women. J Clin Endocrinol Metab (1999) 1.44
Some biochemical effects of asbestos on macrophages. Br J Exp Pathol (1972) 1.44
The role of macrophages in immune-mediated damage to the peripheral nervous system. Prog Neurobiol (2001) 1.43
Localization of the epidermal growth factor (EGF) receptor within the endosome of EGF-stimulated epidermoid carcinoma (A431) cells. J Cell Biol (1986) 1.43
Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis. Neurology (1999) 1.42
Hispanic cultural norms for health-seeking behaviors in the face of symptoms. Health Educ Behav (2001) 1.41
Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview. J Neuroimmunol (1997) 1.40
Comparison of O6-alkylguanine-DNA alkyltransferase activity based on cellular DNA content in human, rat and mouse tissues. Carcinogenesis (1986) 1.40
Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids. Cancer Res (2000) 1.40
Leech therapy for massive scrotal hematoma following percutaneous transluminal angioplasty. J Urol (1997) 1.40
Towards a european network for multiple sclerosis trials (ENMST). Mult Scler (2003) 1.40
Radiometric estimation of the replication time of bacteria in culture: an objective and precise approach to quantitative microbiology. J Nucl Med (1978) 1.40
["Second opinion centers". Approach for improving the quality of treatment for testicular tumors]. Urologe A (2006) 1.39
Out-of-hospital intravenous cannulation: the perspective of patients treated by London Ambulance Service paramedics. Acad Emerg Med (2000) 1.38
[Physical trauma and multiple sclerosis]. Nervenarzt (1997) 1.38
Adhesion molecules in inflammatory bowel disease. Gut (1995) 1.36
Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting. J Clin Endocrinol Metab (1997) 1.36
Optimization of 4-phenylamino-3-quinolinecarbonitriles as potent inhibitors of Src kinase activity. J Med Chem (2001) 1.36
Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease. Blood (2000) 1.35
The in vivo effects of asbestos on macrophage membrane structure and population characteristics of macrophages: a scanning electron microscope study. J Reticuloendothel Soc (1976) 1.35
New expression of myelomonocytic antigens by microglia and perivascular cells following lethal motor neuron injury. J Neuroimmunol (1990) 1.34
Substance P: binding properties and studies on cellular responses in guinea pig macrophages. J Immunol (1986) 1.34
Receptor-mediated endocytosis of transferrin and epidermal growth factor receptors: a comparison of constitutive and ligand-induced uptake. J Cell Sci Suppl (1985) 1.33
O6 alkylguanine-DNA alkyltransferase activity in human myeloid cells. J Clin Invest (1985) 1.33
Localisation of the protein and glycoprotein components of bovine nasal epithelial desmosomes by immunoelectron microscopy. EMBO J (1987) 1.33
Transcription and processing signals in the 3-phosphoglycerate kinase (PGK) gene from Aspergillus nidulans. Gene (1986) 1.33
Platelet activating factor (PAF) induces the oxidative burst in macrophages. Int J Immunopharmacol (1983) 1.31
Severity of osteopenia in estrogen-deficient women with anorexia nervosa and hypothalamic amenorrhea. J Clin Endocrinol Metab (1999) 1.31
The effects of vasopressin on human facial responses related to social communication. Psychoneuroendocrinology (2004) 1.31
Production and assay of the interleukins. J Immunol Methods (1985) 1.31
HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors. The REDS investigators. Neurology (1997) 1.30
Molecular mechanisms of microglial activation. Adv Neuroimmunol (1996) 1.29
Molecular analysis of the argB gene of Aspergillus nidulans. Mol Gen Genet (1986) 1.28
Estrogen mediates sex differences in stress-induced prefrontal cortex dysfunction. Mol Psychiatry (2004) 1.28
Effects of monocyte chemoattractant protein 1 on blood-borne cell recruitment after transient focal cerebral ischemia in mice. Neuroscience (2009) 1.28
The DiGeorge syndrome. I. Clinical evaluation and course of partial and complete forms of the syndrome. Eur J Pediatr (1988) 1.27
Erectile function after anterior urethroplasty. J Urol (2001) 1.26
Desmopressin response of enuretic children. Effects of age and frequency of enuresis. Am J Dis Child (1983) 1.26
The effects of asbestos on macrophages. CRC Crit Rev Toxicol (1978) 1.25